Published in Indian Journal of Endocrinology and Metabolism, the study finds that patients without diabetes lost more than double the weight compared to those with the condition.
With semaglutide patent ending, Indian pharma firms are set to launch lower-cost versions, prompting hospitals and clinics to expand obesity services ahead of a surge in demand.
Semaglutide, active ingredient in popular weight-loss drugs, including Ozempic and Wegovy, belongs to the class of medications known as GLP-1 receptor agonists.
Interest in GLP-1s for addiction has grown in the past decade, as some people prescribed them for diabetes or weight loss noticed they were drinking less alcohol or smoking less.
The panel discussing Ambrish Mithal and Shivam Vij’s book on obesity and weight loss drugs included Minister of State Jitendra Singh, actor Sharmila Tagore, and HT Media chairperson Shobhana Bhartia.
Pakistan's SSG team was not adequately provisioned for the inclement weather. If it managed to consolidate its position, the story of Siachen would have been different.
The reopening of the Strait of Hormuz eases supply fears, but controlled shipping, slow output recovery, and high costs may delay oil flow normalisation for months.
This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS